Davidson, J. R., Waisberg, J. L., Brundage, M. D., & MacLean, A. W. (2001). Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psycho-Oncology, 10, 389–397.

DOI Link

Study Purpose

To examine the initial efficacy of a sleep therapy program developed for treating insomnia in patients with cancer.

Intervention Characteristics/Basic Study Process

Participants received multimodal cognitive-behavioral therapy in five weekly group therapy sessions followed by a final sixth session held four weeks later. The sessions included stimulus control therapy, relaxation training, sleep consolidation strategies, and strategies to reduce cognitive-emotional arousal. Outcomes measured included several sleep-related measures, and several European Organisation for Research and Treatment of Cancer Quality of Life Questionnare (EORTC QLQ-C30) measures, including role functioning, insomnia, and fatigue.

Sample Characteristics

  • The study was comprised of 14 participants, 12 of whom completed the study.
  • Mean age was 54.7 years.
  • Participants had mixed cancer diagnoses.
  • Mean time from diagnosis was 33.6 months.

Setting

The study was conducted at outpatient clinics at a major cancer center in Ontario, Canada.
 

Phase of Care and Clinical Applications

Patients were undergoing the long-term follow-up phase of care.

Study Design

This was a repeated measure, quasiexperimental study with no control group.

Measurement Instruments/Methods

  • Sleep diary
  • Sleep Impairment Index (SII)

Results

Sleep improved from baseline to four weeks and to eight weeks after the intervention. Improved sleep measures included the number of awakenings, wake after sleep onset, and sleep efficiency.

Limitations

  • The study had a small sample size.
  • The participants were relatively healthy.
  • The study only used self-reported data.
  • There was no placebo control group.
  • The duration of effects after eight weeks was unknown.
  • Space was needed to provide the intervention.